Aprotinin associated with increased renal dysfunction, but not with increased cerebrovascular or cardiovascular events

被引：0
作者：
不详
机构：
来源：
FORMULARY | 2007年 / 42卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：441 / 442
页数：2
相关论文
共 3 条
[1]   Evaluating the safety implications of aprotinin use: The retrospective evaluation of aprotinin in cardio thoracic surgery (REACTS) [J].
Coleman, Craig I. ;
Rigali, Vera T. ;
Hammond, Jonathan ;
Kluger, Jeffrey ;
Jeleniowski, Kenneth W. ;
White, C. Michael .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 133 (06) :1547-1552
[2]   Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery [J].
Mangano, Dennis T. ;
Miao, Yinghui ;
Vuylsteke, Alain ;
Tudor, Iulia C. ;
Juneja, Rajiv ;
Filipescu, Daniela ;
Hoeft, Andreas ;
Fontes, Manuel L. ;
Hillel, Zak ;
Ott, Elisabeth ;
Titov, Tatiana ;
Dietzel, Cynthia ;
Levin, Jack .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (05) :471-479
[3]   The risk associated with aprotinin in cardiac surgery [J].
Mangano, DT ;
Tudor, IC ;
Dietzel, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (04) :353-365
1